While Aveanna Healthcare Holdings Inc has underperformed by -0.74%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, AVAH fell by -11.60%, with highs and lows ranging from $6.19 to $2.61, whereas the simple moving average fell by -18.44% in the last 200 days.
On July 02, 2025, Barclays started tracking Aveanna Healthcare Holdings Inc (NASDAQ: AVAH) recommending Equal Weight. A report published by JP Morgan on December 13, 2023, Downgraded its rating to ‘Underweight’ for AVAH. UBS also rated AVAH shares as ‘Sell’, setting a target price of $1.50 on the company’s shares in an initiating report dated November 30, 2023. Credit Suisse January 27, 2023d its ‘Neutral’ rating to ‘Underperform’ for AVAH, as published in its report on January 27, 2023. RBC Capital Mkts’s report from November 21, 2022 suggests a price prediction of $3 for AVAH shares, giving the stock a ‘Sector Perform’ rating. Credit Suisse also rated the stock as ‘Neutral’.
Analysis of Aveanna Healthcare Holdings Inc (AVAH)
Further, the quarter-over-quarter increase in sales is 13.98%, showing a positive trend in the upcoming months.
To gain a thorough understanding of Aveanna Healthcare Holdings Inc’s future performance, several well-rounded types of analysis and research techniques can be used, with equity being among the most crucial. Taking into account the quick ratio of the company, currently set at 1.05, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
It is also very valuable to look at average volume as an indicator of volatility for a stock, and AVAH is recording an average volume of 496.69K. On a monthly basis, the volatility of the stock is set at 4.77%, whereas on a weekly basis, it is put at 3.19%, with a loss of -5.61% over the past seven days. Furthermore, long-term investors anticipate a median target price of $5.91, showing growth from the present price of $4.04, which can serve as yet another indication of whether AVAH is worth investing in or should be passed over.
How Do You Analyze Aveanna Healthcare Holdings Inc Shares?
A leading company in the Medical Care Facilities sector, Aveanna Healthcare Holdings Inc (AVAH) is based in the USA. When comparing Aveanna Healthcare Holdings Inc shares with other companies under Healthcare, the P/E value is an influential factor to note. This is because it represents an indication of the future growth of the company in terms of investors’ expectations. Ultimately, the value of the latter should demonstrate steady, rapid growth, which is an accurate measure of the company’s progress. In addition to the value of 232.18, there is a growth in quarterly earnings of 143.37%.
The number of employees owning shares of the company should also be considered in addition to the fundamentals. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 73.54%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 22.53% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
AVAH shares are owned by institutional investors to the tune of 22.53% at present.
